Lifecore Biomedical Inc. (LFCR) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $4.46 (+0.00%), Market cap $0.17B, 52-week low–high $3.66 ~ $8.82.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedur
Financial statements, price targets, institutional (13F) holdings and related news for Lifecore Biomedical Inc. are updated in real time on BlackAll Trade.
Lifecore Biomedical Inc. trades at $4.46 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Lifecore Biomedical Inc. has a market cap of about $0.17B.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Nether